Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 179 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1781 ? NSCLC 4 Radiation
Antoni van Leeuwenhoek Hospital Netherlands 2/2003
Treatment Details: Patients: This Phase I/II trial involved 55 patients with non-small cell lung cancer. (Tumor stage was I/II in 26 patients, IIIA in 18 patients, and IIIB in 11 patients). Treatment: The
 
1782 ? Hormone refractory prostate cancer 4 Biologic therapy
University of Colorado Cancer Center United States 9/2005
Treatment Details: Patients: This Phase II study involved 18 men with hormone resistent prostate cancer. 13 had bone metastases. Treatment: The treatment consisted of a biological therapy - Trastuzumab (Her
 
1783 ? Hormone refractory prostate cancer 2 Immunotherapy
Karolinska Institute Sweden 8/2004
Treatment Details: Patients: This Phase I trial involved 9 patients with hormone resistent prostate cancer. 5 had metastases in bone, lung, or lymph nodes. Treatment: The treatment consisted of a type of i
 
1784 ? Hormone refractory prostate cancer 3 Biologic therapy
Warren Grant Magnuson Clinical Center, NIH United States 3/2005
Treatment Details: Patients: This Phase II study involved 72 men with hormone refractory malignant prostate cancer with bone metastases. The patients were randomly divided into two groups. Group B had 36 pat
 
1785 ? Hormone refractory prostate cancer 4 Chemotherapy
University of Medicine and Dentistry of New Jersey United States 8/2005
Treatment Details: Patients: This Phase II study enrolled 40 men with metastatic hormone-refractory prostate cancer. The mean age was age 70, and 21 had received prior chemotherapy. Treatment: The treatme
 
1786 ? Advanced prostate cancer 4 Biologic therapy
Cedars-Sinai Medical Center United States 4/2005
Treatment Details: Patients: This phase I study involved 21 patients with various metastatic solid tissue cancers. Twelve patients were men, and nine were women. The median age was 61. Five patients had pro
 
1787 ? Hormone-refractory prostate cancer 3 Hormone
Indiana University United States 9/2005
Treatment Details: Patients: This Phase II study involved 33 patients with hormone-refractory prostate cancer. The median age was 74 years. All but one patient had bone metastases. Treatment: The treatmen
 
1788 ? Stage III Ovarian cancer 3 Immunotherapy
University of Arizona Cancer Center United States 9/2005
Treatment Details: Patients: This phase III study involved 70 evaluable patients women with stage III ovarian cancer. Half the patients received the treatment and half received a placebo. Treatment: The tre
 
1789 ? Advanced Ovarian cancer 4 Chemotherapy
Center for Gynecologic Oncology and Pelvic Surgery United States 9/2005
Treatment Details: Patients: This phase I study involved 10 patients women with advanced high grade ovarian cancer. Treatment: The treatment consisted of two chemotherapy agents - gemcitabine and topotecan.
 
1790 ? Recurrent Ovarian cancer 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 9/2005
Treatment Details: Patients: This phase II study involved 15 women with recurrent ovarian or primary peritoneal cancer. The median age was 54. Treatment: The treatment consisted of two chemotherapy agents -
 
Page 179 of 187  | Previous Page  | Next Page